GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 707 filers reported holding GLAXOSMITHKLINE PLC in Q1 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $11,950,000 | +2.1% | 279,553 | +9.9% | 0.21% | -2.3% |
| Q3 2014 | $11,701,000 | -9.7% | 254,437 | +5.1% | 0.22% | -6.9% |
| Q2 2014 | $12,954,000 | +28.8% | 242,186 | +28.7% | 0.23% | +20.8% |
| Q1 2014 | $10,057,000 | -25.1% | 188,194 | -25.2% | 0.19% | -12.7% |
| Q4 2013 | $13,428,000 | +16.5% | 251,541 | +9.5% | 0.22% | +0.5% |
| Q3 2013 | $11,526,000 | +49.9% | 229,693 | +49.2% | 0.22% | +32.7% |
| Q2 2013 | $7,691,000 | – | 153,956 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |